Kura Oncology Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | 218.8 | 260.1 | 314.8 | 282.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 876.9 | 1,407.2 | 1,405.3 | 1,335.1 | 14.1 | 8.5 | 6.1 | 7.5 | 13.6 | 10.0 | 12.7 | |
| 1.9 | 2.0 | 3.4 | 4.2 | 4.1 | 5.6 | 4.8 | 5.3 | 3.8 | 3.3 | 4.2 | 3.1 | 2.9 | 2.9 | 2.2 | 2.6 | 5.6 | 3.1 | 3.2 | 2.5 | 2.3 | 1.8 | 2.3 | 2.7 | 2.2 | 2.0 | 2.1 | 1.6 | 1.6 | 2.8 | 3.5 | 3.8 | 4.0 | 1.8 | 1.6 | 1.7 | 3.2 | 5.3 | 6.7 | 20.2 | |
| – | – | – | – | – | – | – | – | – | 215.3 | 256.1 | 267.8 | 262.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 856.0 | 1,383.0 | 1,378.3 | 1,304.9 | 10.1 | 7.9 | 5.3 | 6.7 | 11.5 | 9.6 | 11.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.7 | 5.2 | 4.1 | 9.4 | – | – | – | |
| -20.4% | -22.4% | -15.6% | -14.6% | -7.6% | -6.4% | -5.5% | -6.5% | -6.9% | -9.1% | -7.9% | -6.8% | -7.4% | -8.8% | -13.4% | -7.4% | -3.9% | -3.7% | -4.3% | -6.7% | -8.1% | -11.3% | -10.2% | -9.1% | -11.7% | -13.2% | -13.7% | -14.8% | -16.7% | -11.2% | -7.7% | -8.7% | -10.0% | 17.7% | 19.2% | 24.2% | 10.7% | -7.7% | -11.8% | -12.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -66.9% | -69.1% | -68.2% | -67.6% | 98.8% | 99.4% | 99.8% | 96.9% | 95.2% | 94.7% | 94.7% | |
| – | – | – | – | – | – | – | – | – | -2,581.4% | -2,579.8% | -2,605.0% | -2,674.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13,055.4% | -14,463.8% | -15,755.2% | -17,126.1% | -358.5% | -299.2% | -263.8% | -230.5% | -449.9% | -443.5% | -411.9% | |
| – | – | – | – | – | – | – | – | – | -2,481.4% | -2,454.1% | -2,462.5% | -2,519.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12,018.2% | -13,235.2% | -14,311.0% | -15,555.3% | -322.9% | -267.5% | -236.8% | -208.5% | -412.9% | -411.2% | -384.3% | |
| – | – | – | – | – | – | – | – | – | -1,997.3% | -2,054.8% | -2,130.3% | -2,095.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,841.9% | -10,867.1% | -12,192.5% | -13,325.8% | 248.4% | 162.6% | 147.5% | 79.9% | -104.8% | -117.9% | -152.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -41.9% | -48.5% | -56.7% | -67.9% | -35.9% | -44.4% | -34.1% | -44.0% | -31.6% | -37.5% | -40.0% | -24.3% | -26.3% | -28.9% | -33.7% | -22.9% | -26.5% | -14.7% | -17.3% | -20.5% | -23.2% | -25.8% | -27.8% | -29.7% | -32.3% | -32.3% | -34.8% | -30.4% | -33.3% | -38.4% | -33.3% | -39.0% | -46.6% | -42.1% | -49.9% | -64.5% | -89.4% | -160.0% | -273.0% | -612.8% | |
| -35.0% | -39.5% | -46.0% | -53.0% | -31.1% | -37.0% | -30.0% | -38.1% | -28.8% | -33.1% | -35.2% | -22.6% | -24.1% | -26.1% | -30.2% | -21.0% | -24.0% | -13.8% | -16.3% | -19.5% | -22.1% | -24.4% | -26.5% | -28.3% | -30.2% | -29.8% | -32.3% | -28.3% | -30.2% | -34.0% | -30.3% | -35.3% | -41.3% | -22.9% | -24.5% | -28.9% | -33.4% | -37.7% | -45.1% | -50.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 0.5 | 4.9 | -3.3 | -4.8 | -16 | -4.3 | -19 | -11 | -14 | -8.6 | -9.8 | -115 | -47 | -18 | -26 | -126 | -68 | -316 | -102 | -37 | -37 | -88 | -32 | -37 | -89 | -40 | -16 | -38 | -18 | -26 | -31 | -34 | -38 | -213 | -40 | -71 | -84 | -138 | -28 | -59 | |
| 83.4% | 81.5% | 81.1% | 78.1% | 86.5% | 83.3% | 88.2% | 86.7% | 91.2% | 88.3% | 88.2% | 92.8% | 91.7% | 90.4% | 89.7% | 91.3% | 90.3% | 94.4% | 94.5% | 95.5% | 95.1% | 94.9% | 95.5% | 95.3% | 93.7% | 92.1% | 92.8% | 92.9% | 90.7% | 88.5% | 91.2% | 90.5% | 88.5% | 54.4% | 49.0% | 44.8% | 37.3% | 23.6% | 16.5% | 8.2% | |
| 0.1 | 0.3 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.42 | -1.44 | -1.46 | -1.50 | -1.32 | -1.21 | -1.34 | -1.50 | -1.46 | -1.59 | -1.57 | -1.54 | -1.36 | -1.39 | -1.51 | -1.43 | -1.44 | -1.53 | -1.53 | -1.72 | -1.87 | -1.96 | -1.99 | -2.00 | -2.03 | -2.00 | -2.01 | -2.00 | -1.85 | -1.97 | -2.00 | -2.10 | -2.27 | -2.00 | -2.08 | -2.25 | -2.47 | -3.16 | -3.32 | -3.34 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.06 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.62 | 0.78 | 0.95 | 1.19 | 0.77 | 0.81 | 0.87 | |
| 3.38 | 2.97 | 2.58 | 2.21 | 3.66 | 2.73 | 3.92 | 3.41 | 4.62 | 4.23 | 3.92 | 6.33 | 5.16 | 4.83 | 4.47 | 6.24 | 5.43 | 10.40 | 8.85 | 8.43 | 8.04 | 7.61 | 7.15 | 6.74 | 6.27 | 6.20 | 5.78 | 6.59 | 5.57 | 5.14 | 6.02 | 5.38 | 4.87 | 4.75 | 4.17 | 3.49 | 2.77 | 1.98 | 1.22 | 0.55 | |
| -1.29 | -1.32 | -1.37 | -1.36 | -1.14 | -0.97 | -1.03 | -1.19 | -1.22 | -1.28 | -1.31 | -1.33 | -1.13 | -1.21 | -1.34 | -1.20 | -1.19 | -1.23 | -1.21 | -1.41 | -1.52 | -1.59 | -1.64 | -1.67 | -1.61 | -1.63 | -1.67 | -1.57 | -1.52 | -1.62 | -1.64 | -1.79 | -1.95 | 1.54 | 1.26 | 1.40 | 0.95 | -0.80 | -0.95 | -1.32 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.